|
:
- To enhance safety and security of the healthcare supply chain while creating added efficiencies to business practices.
- To identify and develop an IT blueprint to facilitate item-level data sharing across the supply chain data among trading partners.
- To advance adoption of these procedures and practices for sharing product data within the healthcare supply chain.
- To provide insights regarding the ROI of data management/sharing via the data sharing blueprint.
Project in two phases:
Phase I) Rules of Engagement: A Qualitative Business Case for Data Management and Sharing in the Pharmaceutical Supply Chain
The Center’s data management/data sharing initiative, The Rules of Engagement: Data Management and Data Sharing in the Healthcare Supply Chain, was initiated in 2005 by partnering with Rutgers University to assess and develop a business case for data sharing throughout the healthcare supply chain. The Phase I research resulted in the documentation of an industry-wide desire for a common approach, a Blueprint, to facilitate data management and sharing across the supply chain.
The Center expresses it gratitude to the following companies that provided the financial support to make this study possible.
Pfizer U.S. Pharmaceuticals Group, Div, of Pfizer, Inc.
Centocor, Inc.
Ortho-Biotech Product, L.P.
Ortho-McNeil Janssen Pharmaceutical Services
Scios, Inc.
Pharmaceutical Research and Manufacturers of America (PhRMA)
National Association of Chain Drug Stores (NACDS)
AmerisourceBergen Drug Company
Cardinal Health, Inc.
McKesson Supply Solutions
Cephalon, Inc.
- Click here for the executive summary
- Click here for the complete report
Rules of Engagement: Phase II • The Blueprint for Data Management & Data Sharing
Prompted by the Phase I business case, the Center retained Forrester Research, Inc. to develop the desired data sharing Blueprint. This second phase identified key criteria for a data sharing model. The criteria included its ability to:
- Meet or exceed current and anticipated State and Federal laws/regulations
- Evolve beyond regulatory compliance to support increased operational efficiency
- Enable industry-wide visibility to heightened awareness of suspicious or unusual activity
- Tightly manage access to shared data.
The developed model, i.e. Blueprint, ultimately delivered a data management/sharing vision for the supply chain and was presented to the industry late 2007.
The Center expresses it gratitude to the following companies that provided the financial support to make this study possible.
AmerisourceBergen Drug Company
Apotex Corp.
Axway, Inc.
Baxter Healthcare
Centocor, Inc.
Cephalon Inc.
Edge Dynamics, Inc.
Eisai Inc.
Genentech, Inc.
GHX
GlaxoSmithKline
IBM Corporation
Johnson & Johnson Sales & Logistics Company
McKesson Supply Solutions
MedPointe Pharmaceuticals
Ortho-Biotech Products, LP
Ortho-McNeil Janssen Pharmaceutical Services
Pfizer, Inc.
Procter & Gamble Pharmaceuticals
Ranbaxy Pharmaceuticals, Inc.
Scios, Inc.
Upsher-Smith Laboratories, Inc.
US Oncology Specialty, LP
Wyeth Pharmaceuticals, Inc.
- Click here for the executive summary
- Click here to order the full report
To learn more about the research, please contact Karen Ribler, kribler@hdmanet.org.
|